BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27

• Press Releases

  Adolore BioTherapeutics Announces Publication Demonstrating Biosafety and Efficacy of Kv7 Activating rdHSV-CA8* Analgesic Gene Therapy for Chronic Pain via the Intra-Articular Route in Mice

  June 16, 2025

   · 

  6 min read
• Press Releases

  Statement from the Alzheimer’s Drug Discovery Foundation on the Passing of ADDF Co-Founder and Co-Chairman Leonard A. Lauder

  June 16, 2025

   · 

  4 min read
• Press Releases

  EHA 2025 | Multiple Studies Report Encouraging Data of Olverembatinib in Ph+ ALL

  June 16, 2025

   · 

  11 min read
• Press Releases

  Prof. Gang Zheng to Share Insights on Theranostic Lipid Nanoparticles in Exclusive BOC Sciences Webinar

  June 16, 2025

   · 

  2 min read
• Press Releases

  Subgroup Analysis of Cadonilimab as First-Line Therapy for Advanced Cervical Cancer Reported in an Oral Presentation at ASCO 2025

  June 16, 2025

   · 

  6 min read
• Press Releases

  Ethris Signs Strategic Collaboration with Thermo Fisher Scientific to Provide Access to mRNA Technology Platforms

  June 16, 2025

   · 

  3 min read
• Press Releases

  Tonix Pharmaceuticals Announces Appointment of Commercial Industry Veteran, James “Jim” Hunter, to Board of Directors

  June 16, 2025

   · 

  10 min read
• Press Releases

  BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease

  June 16, 2025

   · 

  6 min read
• Press Releases

  Panavance Therapeutics Announces Promising Misetionamide (GP-2250) Phase 1 Clinical Trial Interim Findings in Pancreatic Cancer at BIO 2025

  June 16, 2025

   · 

  3 min read
• Press Releases

  InspireMD Announces CE Mark Approval for CGuard® Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of Stroke

  June 16, 2025

   · 

  5 min read